The American Diabetes Association recently promean blood glucose was 5.0 mmol/l and a significant excess of major IHD events occurred above this posed a new, lower, cut-point of 7.0 mmol/l for diagnosis of diabetes mellitus. We examined data point even when the data were fully adjusted for all other IHD risk factors. Risk of major IHD was from the Caerphilly and Speedwell cohorts to determine possible cut-points of fasting plasma glucose greatest for non-diabetic men with plasma glucose levels between 7.0 and 7.7 mmol/l. Under for increased risk of subsequent ischaemic heart disease (IHD). Men (n=4860) from the general 7.0 mmol/l, the excess event rate was modest, however. Glucose levels were not associated with excess population of a town in South Wales and a practicebased population in Bristol aged 45-63 years were all-cause mortality among these non-diabetic men. These data, based on the excess risk of macrofirst examined in 1979-83, and re-examined at intervals, and these data relate to follow-up at about vascular disease experienced by a British cohort of non-diabetic men, accord with the proposals to base 10 years (120 months, Caerphilly) (112 months, Speedwell). Clinically recognized diabetics (n=94) the diagnosis of diabetes on a cut point of 7.0 rather than 7.8 mmol/l. experienced a higher mortality rate and an excess number of major IHD events. Among non-diabetics,
Introduction
The American Diabetes Association recently reported udinal studies-the Baltimore Longitudinal Study of Aging3 from the United States and from the Paris the findings of its expert committee on the diagnosis and classification of diabetes mellitus.1 Their prinProspective Study.4 A recent report from the European Diabetes Epidemiology Study Group5 examined the cipal recommendation is that, for epidemiological studies, estimates of diabetes prevalence and incideffect on the prevalence of diabetes mellitus of adopting the diagnostic criterion proposed by the ence should be based on a fasting plasma glucose (FPG) of 126 mg/dl or less (7.0 mmol/l). The World American Diabetes Association in populations from eight European countries; their report noted a high Health Organization definition2 was based on a cutpoint of Á140 mg/dl (7.8 mmol) for FPG or a 2-h rate of disagreement in the classification of diabetes based on the two different diagnostic criteria. They plasma glucose of Á200 mg/dl (11.1 mmol/l) in a standard oral glucose tolerance test.
proposed that prospective data should be examined to evaluate risk of subsequent disease in subjects Evidence relating to the threshold values for glucose at which subsequent risk of macrovascular classified by each method. The present report provides evidence for fasting plasma glucose from British disease was increased was obtained from two longit-surveys-the Caerphilly and Speedwell collaborative sion of the International Classification of Diseases (ICD)-were used as the basis for a search of hospital study, in which men were first examined in 1979-83. notes for events which satisfied the World Health Organization (WHO) criteria for definite acute myocardial infarction.9 For men who had died before
Methods the end of follow-up, a copy of the death certificate
Study populations
was automatically received from the National Health Service Central Register. From this information, three In Caerphilly, a 100% sample of men was selected categories of incident IHD events were defined: IHD from within a defined area. They were aged between death, clinical non-fatal myocardial infarction and 45 and 59 years when first examined. A total of electrocardiographic myocardial infarction, as previ-2512 men were seen-89% of the 2818 found to ously described.6,7 A major IHD event was defined be eligible. In Speedwell, a 100% sample of men as one or more of the three possible outcomes was selected from the age-sex registers of 16 general described above. practitioners working from two neighbouring health centres. The men chosen were aged 45-59 years when chosen, immediately before the study began Laboratory methods in 1978; thus they were aged between 45 and 63
All blood samples were taken with minimum haemoyears when first examined. A total of 2348 men stasis after an overnight fast. Plasma glucose was were seen during the following 3 years, 92% of measured for both studies in the same laboratory those eligible. The combined cohort thus numbers using a Beckman Astra 8 analyser at Frenchay 4860 men.
Hospital, Bristol. This analyser used the oxygen rate method10 to measure glucose and a Beckman standSurvey methods and follow-up procedure ard for reference values. The laboratory participated in the South-West Regional Hospitals' Quality The two studies had a common core protocol and common training procedures for medical and nonControl scheme which provides common standards for laboratory parameters. The normal fasting plasma medical observers. These have been described in detail elsewhere.6,7 Briefly, at recruitment, the men glucose values were in the standard range 4.0-6.0 mmol/l. A 5% sample of subjects provided attended an afternoon or evening clinic at which a standard medical and smoking history was obtained; a duplicate blood sample for glucose determination. This was presented blindly to the laboratory, and the the London School of Hygiene and Tropical Medicine Chest Pain questionnaire was administered; height overall coefficient of variation of the duplicate pairs was <5%. Laboratory methods and their accuracy was measured using Holtain stadiometers and weight was recorded using calibrated beam balances. Blood for the plasma lipids have been reported in detail previously.7 pressure was recorded by trained medical observers using Hawksley 'random zero' sphygmomanometers for the majority of observations. A standard-
Statistical methods
ized 12-lead electrocardiogram (ECG) was recorded. ECGs were coded using the Minnesota coding Analysis of events during follow-up used multiple logistic regression with the occurrence, or not, of a system8 by two experienced observers. Men were asked whether or not they had ever been diagnosed major IHD event as the principal outcome variable. Men with evidence of IHD when first examined as having diabetes. They then returned, after an overnight fast, to an early morning clinic where a were not excluded from the analyses, but their increased risk was allowed for by including preblood sample was taken with minimal venous stasis. Fasting samples were obtained from 4641 men.
existing IHD as a factor in the regression model. In this instance a broad epidemiological definition of The results reported in this paper refer to the second follow-up in Caerphilly. This was at a nearly pre-existing IHD was used; men with severe chest pain and/or angina on the Chest Pain questionnaire constant interval of 120 months (SD 6 months). In Speedwell results related to the third follow-up and and/or probable or possible ECG ischaemia according to the Whitehall criteria.11 Death from any cause the mean interval was 112 months (SD 3 months).
At each follow-up the Chest Pain Questionnaire was also analysed as a separate outcome variable. Risks for men in different categories of blood glucose was again administered, and a further ECG recorded. The Chest Pain Questionnaire was extended to level were compared in the logistic model by a likelihood ratio x2 test and by a x2 test for linear include questions about hospitalization for severe chest pain. These, together with Hospital Activity trend across the categories. Any possible difference in incidence between the Analysis notifications of admissions coded as 410 to 414-ischaemic heart disease (IHD) in the 9th revitwo study areas, for example, arising from their slightly different lengths of follow-up, was allowed with various glucose levels, independent of other risk factors. The following variables were included for by including area as a two-level factor in the logistic model. The assumption that the IHD risk as potential confounders: age, smoking habit (never, ex-or current), pre-existing IHD, diastolic blood associated with various glucose levels in the two areas was the same was tested by including interpressure, body mass index, total cholesterol, HDLcholesterol and log triglyceride. Table 2 shows that, actions with area in the model; none was found to be statistically significant. No time-to-event was using a value of <5 mmol/l as a baseline, subjects with higher values than this showed increased risk available for incidence cases of IHD defined by significant changes in the Minnesota ECG codes.
of subsequent IHD when adjusting for all other major risk factors (x2=10.8, df=4; p=0.03). A trend in Time-to-event analyses were not performed for this reason and because the average length of follow-up increased risk of IHD is apparent (x2=7.23, df=1; p=0.0007) although the relative odds are greatest was nearly constant within each area.
in men with glucose levels which were between 7.0 and 7.8; men with higher levels had a rather lower estimated risk, but this was non-significantly different
Results from risk in the former group. The pooled risk for Ninety-four subjects said that they had been given a men with glucose levels of 7.0 mmol/l and above diagnosis of diabetes by their general practitioner or was 1.93 (95% CI 1.05-3.57). a consultant physician prior to our baseline examination. Of these 44 were receiving dietary advice only, 25 were taking oral hypoglycaemics and 22 used Discussion insulin; there was no information for the remaining three. Table 1 shows the subsequent all-cause mortalThese data support the common finding of excess mortality from all causes and increased risk of IHD ity and incidence of IHD (fatal and non-fatal IHD events) in these diabetics and in non-diabetics.
among men with diabetes. Mortality and incident IHD were also increased among previously unrecogMortality and incident IHD were significantly higher in diabetics than in non-diabetics, and diabetics who nized diabetics according to the current WHO criteria of fasting glucose levels of 7.8 mmol/l or above, received medical therapy were at higher risk than those on diet only.
although this did not achieve formal statistical significance, possibly due to small numbers. As has been The mean age of diabetics and non-diabetics was similar, but the mean body mass index of the known reported elsewhere,9-12 there is evidence of increased risk of IHD in non-diabetics with above-average non-insulin-dependent diabetics (27.0 kg/m2) was significantly higher than that of non-diabetics glucose levels. A recent report13 based on British prospective studies suggests that excess mortality due (25.9 kg/m2).
For the purposes of the present analysis, unrecogto cardiovascular disease is due to the association of non-insulin-dependent diabetes mellitus with other nized diabetics were included among the nondiabetic subjects since no intervention would have cardiovascular risk factors, and a review of studies14 summarized the evidence that hyperglycaemia was been offered prior to baseline examination. All further analyses are based on 4511 non-diabetic men in an independent cardiovascular risk factor as 'weak and inconsistent' in non-diabetic subjects. A more the combined cohort who had a fasting glucose measurement.
recently published analysis15 of 20-year prospective data from three populations found that increased Multiple logistic regression analyses were performed in order to assess the excess risk associated mortality (particularly from IHD) occurred mainly small numbers produce wide confidence intervals.
Populations from 21 countries in four continents.
As Table 2 shows, 40% of this population of non- should be reduced to 7.0 mmol/l is consistent with these data.
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